Pontifax Venture Capital

Portfolio Companies 2026 for Pontifax Venture Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Pontifax Venture Capital accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $855M. The median disclosed raise is $124M, and the largest is Silverback Therapeutics at $210M, ahead of Step Pharma ($146M) and Adcytherix ($144M).

The names that recur most often on these portfolio cap tables are Pontifax Venture Capital (8 companies), Kurma Partners (4 companies), Bpifrance (3 companies), RA Capital Management (3 companies), OrbiMed Advisors (2 companies), V-Bio Ventures (2 companies). By latest disclosed round, the market skews Series A (3), Series C (2), Series B (2), Growth (1).

Best funded Pontifax Venture Capital companies

  1. Silverback Therapeutics — $210M (latest: Series C)
  2. Step Pharma — $146M (latest: Series C)
  3. Adcytherix — $144M (latest: Series A)
  4. Precirix — $124M (latest: Series B)
  5. Emergence Therapeutics — $94M (latest: Series A)
  6. Saniona — $65M (latest: Growth)
  7. FoRx Therapeutics — $61M (latest: Series A)
  8. Germitec SAS — $11M (latest: Series B)

Pontifax Venture Capital — related firms and companies (51)

Pontifax Venture Capital alternatives · All research reports